AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Ben-Menachem, E
Citation: E. Ben-menachem, Proof of efficacy trials: seizure types, EPILEPSY R, 45(1-3), 2001, pp. 31-34

Authors: Ben-Menachem, E
Citation: E. Ben-menachem, Monotherapy trials: prerequisite data - Discussion, EPILEPSY R, 45(1-3), 2001, pp. 65-66

Authors: Ben-Menachem, E
Citation: E. Ben-menachem, Vagus nerve stimulation, side effects, and long-term safety, J CL NEURPH, 18(5), 2001, pp. 415-418

Authors: Malmgren, K Ben-Menachem, E Frisen, L
Citation: K. Malmgren et al., Vigabatrin visual toxicity: Evolution and dose dependence, EPILEPSIA, 42(5), 2001, pp. 609-615

Authors: Ben-Menachem, E
Citation: E. Ben-menachem, Untitled, ACT NEUR SC, 103(1), 2001, pp. 1-1

Authors: Ben-Menachem, E Kyllerman, M Marklund, S
Citation: E. Ben-menachem et al., Superoxide dismutase and glutathione peroxidase function in progressive myoclonus epilepsies, EPILEPSY R, 40(1), 2000, pp. 33-39

Authors: Ben-Menachem, E Falter, T
Citation: E. Ben-menachem et T. Falter, Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: A multicenter, double-blind, responder-selected study evaluating monotherapy, EPILEPSIA, 41(10), 2000, pp. 1276-1283

Authors: Ben-Menachem, E Henriksen, O Johannessen, SI
Citation: E. Ben-menachem et al., Diagnosis and treatment of partial seizures, CNS DRUGS, 11(1), 1999, pp. 23-39

Authors: Ben-Menachem, E
Citation: E. Ben-menachem, The clinical efficacy of topiramate in the treatment of epilepsy, REV CONT PH, 10(3), 1999, pp. 163-184

Authors: Ben-Menachem, E
Citation: E. Ben-menachem, Vigabatrin, HANDB EXP P, 138, 1999, pp. 375-394

Authors: Spanaki, MV Siegel, H Kopylev, L Fazilat, S Dean, A Liow, K Ben-Menachem, E Gaillard, WD Theodore, WH
Citation: Mv. Spanaki et al., The effect of vigabatrin (gamma-vinyl GABA) on cerebral blood flow and metabolism, NEUROLOGY, 53(7), 1999, pp. 1518-1522

Authors: Ben-Menachem, E Hellstrom, K Waldton, C Augustinsson, LE
Citation: E. Ben-menachem et al., Evaluation of refractory epilepsy treated with vagus nerve stimulation forup to 5 years, NEUROLOGY, 52(6), 1999, pp. 1265-1267

Authors: Cramer, JA Fisher, R Ben-Menachem, E French, J Mattson, RH
Citation: Ja. Cramer et al., New antiepileptic drugs: Comparison of key clinical trials, EPILEPSIA, 40(5), 1999, pp. 590-600
Risultati: 1-13 |